bpc 157 pros BPC-157 for athletes and injury treatment: Science, safety, and legal concerns BPC-157: Miracle Healing Peptide or

Peripheral (intraperitoneal, subcutaneous) BPC-157 administration produces CNS effects suggesting either peripheral central signalling through vagal or blood-borne pathways, or direct BBB penetrance

PMID: 20190676

According to Sara Talpos of the science magazine Undark , a company partly owned by Sikiric sponsored a 2015 trial, at a hospital in Tijuana, that tested the safety of an oral version of BPC-157

Fewer than 1 in 5 Americans (16%) said they knew a lot about Alzheimer's disease, and even fewer said they knew much about MCI or other diseases that cause dementia (Figure 19)

Actions to proactively manage dementia Proactive management of Alzheimer's and other dementias can improve the quality of life of affected individuals and their caregivers